Biliary tract cancer and stones in relation to chronic liver conditions: A population-based study in Shanghai, China

被引:32
|
作者
Hsing, Ann W.
Gao, Yu-Tang
McGlynn, Katherine A.
Niwa, Shelley
Zhang, Mingdong
Han, Tian-Quan
Wang, Bing-Sheng
Chen, Jinbo
Sakoda, Lori C.
Shen, Ming-Chang
Zhang, Bai-He
Deng, Jie
Rashid, Asif
机构
[1] Natl Canc Inst, Div Canc Epidemiol & Genet, Rockville, MD 20852 USA
[2] Shanghai Canc Inst, Shanghai, Peoples R China
[3] Hlth Studies Sector, Rockville, MD USA
[4] Chinese Univ Hong Kong, Ctr Emerging Infect Dis, Hong Kong, Peoples R China
[5] Raijin Hosp, Dept Surg, Shanghai, Peoples R China
[6] Shanghai Med Univ, Zhongshan Hosp, Dept Surg, Shanghai 200032, Peoples R China
[7] Sch Med, Dept Epidemiol & Biostat, Philadelphia, PA USA
[8] Shanghai Tumor Hosp, Dept Pathol, Shanghai, Peoples R China
[9] Second Mil Hosp, Dept Surg, Shanghai, Peoples R China
[10] Univ Texas, MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA
关键词
biliary tract cancer; family history; viral hepatitis; liver cirrhosis; family history of liver cancer; China;
D O I
10.1002/ijc.22375
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Biliary tract cancers are relatively rare but fatal tumors. Apart from a close link with gallstones and cholangitis, risk factors for biliary tract cancer are obscure. Chronic liver conditions, including liver cirrhosis, have been linked to a higher risk of biliary tract cancer. In a population-based case-control study conducted in Shanghai, China, we investigated the relationships of a history of chronic hepatitis and liver cirrhosis as well as a family history of liver cancer with biliary tract cancer risk. The study included 627 patients with biliary tract cancers (368 gallbladder, 191 bile duct and 68 ampulla of Vater), 1,037 patients with biliary stones (774 gallbladder stones and 263 bile duct stones) and 959 healthy subjects randomly selected from the population. Bile duct cancer was associated with self-reports of chronic liver conditions, including a history of chronic hepatitis (OR = 2.0, 95% CI 0.9-4.4), liver cirrhosis (OR = 4.7, 95% CI 1.9-11.7) and a family history of primary liver cancer (OR = 2.0, 95% CI 1.0-3.9). The excess risk persisted after adjustment for gallstones and were more pronounced among subjects without gallstones (OR = 5.0, 95% CI 1.3-20.0 and OR = 4.9, 95% 2.0-12.2, respectively). History of liver conditions was also associated with an excess of biliary stones (OR = 1.9, 95% CI 1.2-3.0). No association was found for cancers of the gallbladder and ampulla of Vater. A history of chronic hepatitis and cirrhosis may be risk factors for extraheptic bile duct cancer. Given that chronic infection with hepatitis B virus (HBV) is the most common cause of liver disease in China, serologic markers of HBV need to be measured in future studies to examine the link between HBV and bile duct cancer. (c) 2007 Wiley-Liss, Inc.
引用
收藏
页码:1981 / 1985
页数:5
相关论文
共 50 条
  • [41] Variants in circadian genes and prostate cancer risk: a population-based study in China
    L W Chu
    Y Zhu
    K Yu
    T Zheng
    H Yu
    Y Zhang
    I Sesterhenn
    A P Chokkalingam
    K N Danforth
    M-C Shen
    F Z Stanczyk
    Y-T Gao
    A W Hsing
    Prostate Cancer and Prostatic Diseases, 2008, 11 : 342 - 348
  • [42] The Epidemiological Landscape of Thyroid Cancer and Estimates of Overdiagnosis in China: A Population-Based Study
    Zhu, Qixun
    Liu, Junli
    Hu, Junrong
    Zhang, Yanting
    THYROID, 2025,
  • [43] Survey of hepatitis B virus infection for liver cancer screening in China: A population-based, cross-sectional study
    Xu Yongjie
    Xia Changfa
    Li He
    Cao Maomao
    Yang Fan
    Li Qianru
    Cao Mengdi
    Chen Wanqing
    中华医学杂志英文版, 2024, 137 (12)
  • [44] Development of a population-based cancer case-control study in southern china
    Ye, Weimin
    Chang, Ellen T.
    Liu, Zhiwei
    Liu, Qing
    Cai, Yonglin
    Zhang, Zhe
    Chen, Guomin
    Huang, Qi-Hong
    Xie, Shang-Hang
    Cao, Su-Mei
    Shao, Jian-Yong
    Jia, Wei-Hua
    Zheng, Yuming
    Liao, Jian
    Chen, Yufeng
    Lin, Longde
    Liang, Liming
    Ernberg, Ingemar
    Vaughan, Thomas L.
    Huang, Guangwu
    Zeng, Yi
    Zeng, Yi-Xin
    Adami, Hans-Olov
    ONCOTARGET, 2017, 8 (50) : 87073 - 87085
  • [45] Incidence, mortality, and temporal patterns of oropharyngeal cancer in China: a population-based study
    Liu, Jie
    Yang, Xu-li
    Zhang, Si-Wei
    Zhu, Li-Ping
    Chen, Wan-Qing
    CANCER COMMUNICATIONS, 2018, 38
  • [46] Epidemiology of lower urinary tract symptoms in a cross-sectional, population-based study The status in China
    Wang, Jian-Ye
    Liao, Limin
    Liu, Ming
    Sumarsono, Budiwan
    Cong, Min
    MEDICINE, 2018, 97 (34)
  • [47] Cancer survival statistics in China 2019-2021: a multicenter, population-based study ☆
    Zeng, Hongmei
    Zheng, Rongshou
    Sun, Kexin
    Zhou, Maigeng
    Wang, Shaoming
    Li, Li
    Chen, Ru
    Han, Bingfeng
    Liu, Meicen
    Zhou, Jinhui
    Xu, Mengyuan
    Wang, Lijun
    Yin, Peng
    Wang, Baohua
    You, Jinling
    Wu, Jing
    Wei, Wenqiang
    He, Jie
    JOURNAL OF THE NATIONAL CANCER CENTER, 2024, 4 (03): : 203 - 213
  • [48] Increased risk of cancer in chronic dialysis patients: a population-based cohort study in Taiwan
    Lin, Hsuen-Fu
    Li, Yi-Hwei
    Wang, Chih-Hsien
    Chou, Chu-Lin
    Kuo, De-Jhen
    Fang, Te-Chao
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (04) : 1585 - 1590
  • [49] Genitourinary symptoms in urban China: a population-based study
    Parish, William L.
    Hao, Yanni
    Laumann, Edward O.
    Schneider, John
    INTERNATIONAL JOURNAL OF STD & AIDS, 2007, 18 (11) : 736 - 740
  • [50] Malaria in China: a longitudinal population-based surveillance study
    Ding, Cheng
    Huang, Chenyang
    Zhou, Yuqing
    Fu, Xiaofang
    Liu, Xiaoxiao
    Wu, Jie
    Deng, Min
    Li, Lanjuan
    Yang, Shigui
    EPIDEMIOLOGY AND INFECTION, 2020, 148 : 1DUIMMY